These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17473452)

  • 1. Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine.
    Ikawa K; Shimatani T; Hayato S; Morikawa N; Tazuma S
    Biol Pharm Bull; 2007 May; 30(5):1003-6. PubMed ID: 17473452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine.
    Shimatani T; Inoue M; Kuroiwa T; Xu J; Nakamura M; Tazuma S; Ikawa K; Morikawa N
    Dig Dis Sci; 2006 Jan; 51(1):114-20. PubMed ID: 16416222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
    Koike T; Ohara S; Sehine H; Kawamura M; Abe Y; Inomata Y; Iijima K; Imatani A; Shimosegawa T
    Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.
    Yamagishi H; Koike T; Ohara S; Horii T; Kikuchi R; Kobayashi S; Abe Y; Iijima K; Imatani A; Suzuki K; Hishinuma T; Goto J; Shimosegawa T
    World J Gastroenterol; 2008 Apr; 14(15):2406-10. PubMed ID: 18416470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin gene-related peptide and somatostatin releases correlated with the area under the lafutidine concentration-time curve in human plasma.
    Ikawa K; Shimatani T; Azuma Y; Inoue M; Morikawa N
    J Clin Pharm Ther; 2006 Aug; 31(4):351-6. PubMed ID: 16882104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values.
    Iida H; Inamori M; Nozaki Y; Endo H; Hosono K; Akiyama T; Sakamoto Y; Takahashi H; Koide T; Tokoro C; Abe Y; Nakajima A
    BMC Gastroenterol; 2009 Jul; 9():52. PubMed ID: 19589146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin.
    Suzuki T; Kagami T; Uotani T; Yamade M; Hamaya Y; Iwaizumi M; Osawa S; Sugimoto K; Miyajima H; Furuta T
    Eur J Clin Pharmacol; 2018 Jan; 74(1):45-52. PubMed ID: 28986609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and long-lasting action of lafutidine on the human histamine H(2) receptor.
    Fukushima Y; Otsuka H; Ishikawa M; Asano T; Anai M; Katsube T; Ogawa K; Kajiwara T; Ohkawa S; Ishikawa T; Omata M; Saitoh T
    Digestion; 2001; 64(3):155-60. PubMed ID: 11786663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism.
    Nakano M; Kitano S; Nanri M; Kiniwa M
    Eur J Pharmacol; 2011 May; 658(2-3):236-41. PubMed ID: 21349265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Afferent signalling from the acid-challenged rat stomach is inhibited and gastric acid elimination is enhanced by lafutidine.
    Edelsbrunner ME; Nakano M; Holzer P
    BMC Gastroenterol; 2009 Jun; 9():40. PubMed ID: 19490646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lafutidine, a novel histamine H2-receptor antagonist, increases serum calcitonin gene-related peptide in rats after water immersion-restraint stress.
    Sato H; Kawashima K; Yuki M; Kazumori H; Rumi MA; Ortega-Cava CF; Ishihara S; Kinoshita Y
    J Lab Clin Med; 2003 Feb; 141(2):102-5. PubMed ID: 12577045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?
    Inamori M; Togawa J; Iwasaki T; Ozawa Y; Kikuchi T; Muramatsu K; Chiguchi G; Matsumoto S; Kawamura H; Abe Y; Kirikoshi H; Kobayashi N; Shimamura T; Kubota K; Sakaguchi T; Saito S; Ueno N; Nakajima A
    J Gastroenterol; 2005 May; 40(5):453-8. PubMed ID: 15942709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of neutrophil activation by lafutidine, an H2-receptor antagonist, through enhancement of sensory neuron activation contributes to the reduction of stress-induced gastric mucosal injury in rats.
    Harada N; Okajima K
    Dig Dis Sci; 2007 Feb; 52(2):469-77. PubMed ID: 17211693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Properties of Oral Lafutidine Tablets and the Effect of Food on its Pharmacokinetics in Healthy Chinese Subjects.
    Li S; Xu M; Li H; Du J; Li W
    Adv Ther; 2016 Oct; 33(10):1704-1714. PubMed ID: 27444313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
    Amagase K; Ochi A; Sugihara T; Kato S; Takeuchi K
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S111-8. PubMed ID: 20586851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of omeprazole 10 mg on intragastric pH in three different CYP2C19 genotypes, compared with omeprazole 20 mg and lafutidine 20 mg, a new H2-receptor antagonist.
    Shimatani T; Inoue M; Kuroiwa T; Horikawa Y; Mieno H; Nakamura M
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1149-57. PubMed ID: 14653835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma famotidine concentration versus intragastric pH in patients with upper gastrointestinal bleeding and in healthy subjects.
    Echizen H; Shoda R; Umeda N; Ishizaki T
    Clin Pharmacol Ther; 1988 Dec; 44(6):690-8. PubMed ID: 2904311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability.
    Patil S; Talele GS
    Drug Deliv; 2015 May; 22(3):312-9. PubMed ID: 24471787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid. A randomized controlled trial.
    Feldman M
    JAMA; 1996 May; 275(18):1428-31. PubMed ID: 8618369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
    Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
    Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.